- Home
- applications
- pancreas
Show results for
Refine by
Pancreas Product Applications
10 applications found
A very thin probe (S 650) was used to monitor the pancreas of the same mouse over 9 months. ...
ByMauna Kea Technologies based in Paris, FRANCE
Our RASTRUM matrices support a range of pancreatic tissue cell types ranging from diseased to healthy cells (pancreatic carcinoma, pancreatic adenocarcinoma, ...
ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA
Sepsis is one of the leading causes of death worldwide. It is a life-threatening condition caused by a dysregulated host response to infection, which can progress to multiple organ dysfunction, septic shock and even death 1. Every hour counts in sepsis. It’s a medical emergency that requires immediate diagnosis because any delay in treatment can dramatically reduce the chances of survival 2. ...
ByAbionic SA based in Epalinges, SWITZERLAND
Like other nanocarriers, synthetic exosomes can be used to treat different types of cancer successfully, by encapsulating the desired anti-tumoral drug or RNA and enzymes. Several studies have used engineered exosomes from dendritic or macrophage cells to release chemotherapeutic compounds as doxorubicin, paclitaxel miRNA or siRNA to induce antitumoral activity. Rodent mammary carcinoma, mice lung cancer, glioma and pancreatic cancer are just some targeted diseases in preclinical testing using exosome delivery ...
ByNanovex Biotechnologies based in Llanera, SPAIN
Gastric cancer is a disease in which cancer cells form in the lining of the stomach. Almost all gastric cancers are adenocarcinomas, a cancer that begins in glandular tissue. Gastric cancer is often in an advanced stage when it is diagnosed. At this stage, it can often be treated, but rarely ...
ByAscelia Pharma AB based in Malmö, SWEDEN
Type 1 diabetes is a common chronic disease, affecting millions of people throughout the world, in which the immune system attacks the body’s own pancreatic cells, stopping the production of insulin. Though it was previously considered a childhood disease, type 1 diabetes is known to affect people at every age, and it has no ...
ByEli Lilly and Company based in Indianapolis, INDIANA (USA)
The Symbios TPR4000™ has great promise in the field of healthcare beyond its obvious benefits in the manufacture of pharmaceuticals and the treatment of the waste stream that results from the manufacturing process. While these healthcare applications will likely require an FDA approval process, Symbios is partnering with leaders in their respective fields to navigate through the required regulatory approval ...
BySymbios Technologies LLC. based in Fort Collins, COLORADO (USA)
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp® Mobetron® and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
Diabetes occurs when glucose (sugar) builds up in the blood. This buildup causes an inability of the body to use the glucose for energy. This inability happens when the insulin does not function correctly. Many people believe that diabetes is a “sugar problem” but it is actually an “insulin ...
ByProdigy Diabetes Care, LLC based in Charlotte, NORTH CAROLINA (USA)
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)